Naista Zhand

9PUBLICATIONS
1CO-AUTHORS
Intensive careNanotoxicology, health and safetyClinical neuropsychologyMemory and attentionMortality
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Aug 05, 2026
What drives prolonged hospital stays in schizophrenia-spectrum disorders? A Canadian tertiary care review.

|Jun 17, 2026
Safety of Adjunct Low-Dose Methylphenidate Extended-Release for Cognitive Deficits in Stable Schizophrenia: Results From an Open-Label, Randomized Crossover Trial.

|Jan 26, 2026
Efficacy of Low-Dose Adjunctive Methylphenidate Extended-Release on Cognition and Functioning in Individuals With Schizophrenia: A Randomized Open-Label Trial.

Naista Zhand, Ridha Joober, Alain Labelle

|Oct 05, 2023
Pharmacological management of neurocognitive impairment in schizophrenia: A narrative review.

Kyle Arsenault-Mehta, Mario Hochman-Bérard, Alexander Johnson

|Aug 04, 2023
Mortality Rate and Causes of Death in a Canadian Tertiary Schizophrenia Program.

Makenna J Timm, Carrie L Robertson, Naista Zhand

|Jun 14, 2022
Limitations of access to antipsychotics in Canada: loss of the old and unavailability of the new options.

Naista Zhand, Nimisha Desai, Angela Park

Pageof 2

Frequent Collaborators

1 joint publications

Makenna J Timm